X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (505) 505
Publication (46) 46
Book Review (40) 40
Book Chapter (9) 9
Patent (9) 9
Conference Proceeding (7) 7
Book / eBook (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (365) 365
humans (338) 338
female (306) 306
pathology (209) 209
immunohistochemistry (149) 149
middle aged (148) 148
cancer (134) 134
oncology (122) 122
aged (120) 120
adult (116) 116
ovarian neoplasms - pathology (113) 113
ovarian cancer (98) 98
obstetrics & gynecology (89) 89
prognosis (87) 87
tumors (84) 84
ovarian neoplasms - genetics (83) 83
carcinoma (70) 70
expression (68) 68
mutation (67) 67
aged, 80 and over (63) 63
surgery (57) 57
neoplasm staging (54) 54
biomarkers, tumor - analysis (53) 53
abridged index medicus (48) 48
cystadenocarcinoma, serous - pathology (47) 47
diagnosis (45) 45
biomarkers, tumor - metabolism (44) 44
ovarian neoplasms - metabolism (42) 42
tissue array analysis (42) 42
endometrial neoplasms - pathology (41) 41
research (40) 40
genetic aspects (39) 39
ovarian carcinoma (38) 38
ovary (38) 38
adenocarcinoma (37) 37
endometrial cancer (37) 37
p53 (37) 37
analysis (36) 36
cell biology (36) 36
carcinoma, endometrioid - pathology (33) 33
chemotherapy (33) 33
neoplasm grading (33) 33
animals (32) 32
breast cancer (32) 32
kaplan-meier estimate (31) 31
breast-cancer (30) 30
serous carcinoma (30) 30
mutations (29) 29
ovarian neoplasms - diagnosis (29) 29
reproducibility of results (29) 29
biomarkers, tumor - genetics (28) 28
article (27) 27
breast neoplasms - pathology (27) 27
diagnosis, differential (27) 27
male (27) 27
dna mutational analysis (26) 26
gene expression regulation, neoplastic (26) 26
retrospective studies (26) 26
risk factors (26) 26
survival (26) 26
carcinoma - pathology (25) 25
cystadenocarcinoma, serous - genetics (25) 25
disease-free survival (25) 25
obstetrics and gynecology (25) 25
endometrial neoplasms - genetics (24) 24
gene expression (24) 24
cell line, tumor (23) 23
cohort studies (23) 23
gene-expression (23) 23
grade serous carcinoma (23) 23
care and treatment (22) 22
endometrial carcinoma (22) 22
hematology, oncology and palliative medicine (22) 22
stage (22) 22
adenocarcinoma, clear cell - pathology (21) 21
clear-cell carcinoma (21) 21
medical research (21) 21
reproducibility (21) 21
survival analysis (21) 21
breast neoplasms - metabolism (20) 20
endocrine system diseases (20) 20
fallopian-tube (20) 20
gene expression profiling (20) 20
ovarian neoplasms - chemistry (20) 20
ovarian neoplasms - mortality (20) 20
research article (20) 20
canada (19) 19
endometrial neoplasms - metabolism (19) 19
endometrium (19) 19
health aspects (19) 19
in situ hybridization, fluorescence (19) 19
mice (19) 19
predictive value of tests (19) 19
treatment outcome (19) 19
women (19) 19
fallopian tube neoplasms - pathology (18) 18
nuclear proteins - genetics (18) 18
breast neoplasms - genetics (17) 17
carcinoma, endometrioid - genetics (17) 17
estrogen (17) 17
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 26, pp. 2719 - 2729
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 9, pp. 852 - 861
Summary Background Olaparib (AZD2281) is a small-molecule, potent oral poly(ADP-ribose) polymerase (PARP) inhibitor. We aimed to assess the safety and... 
Hematology, Oncology and Palliative Medicine | POLY(ADP-RIBOSE) POLYMERASE | BRCA2 MUTATIONS | LIPOSOMAL DOXORUBICIN | RIBOSE POLYMERASE INHIBITORS | SOLID TUMORS | ONCOLOGY | GENETICS | GUIDELINES | SENSITIVITY | RESISTANCE | PARP INHIBITOR | Humans | Middle Aged | Ovarian Neoplasms - pathology | Carcinoma - mortality | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Time Factors | Aged, 80 and over | Cell Differentiation | Carcinoma - drug therapy | Enzyme Inhibitors - adverse effects | Phthalazines - administration & dosage | Administration, Oral | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | Canada | Breast Neoplasms - genetics | Carcinoma - genetics | Mutation | Receptor, ErbB-2 - analysis | Piperazines - administration & dosage | Receptors, Estrogen - analysis | Ovarian Neoplasms - mortality | Breast Neoplasms - enzymology | Antineoplastic Agents - adverse effects | Carcinoma - enzymology | Adult | Female | Ovarian Neoplasms - drug therapy | Carcinoma - secondary | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Treatment Outcome | BRCA1 Protein - genetics | Disease-Free Survival | Phthalazines - therapeutic use | Poly(ADP-ribose) Polymerases - metabolism | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | BRCA2 Protein - genetics | Phthalazines - adverse effects | Care and treatment | Relapse | Gene mutations | Oncology, Experimental | Breast cancer | Research | Cancer | Diseases | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2012, Volume 109, Issue 3, pp. 929 - 934
14-3-3 proteins are ubiquitously expressed regulators of various cellular functions, including proliferation, metabolism, and differentiation, and altered... 
Proteins | 3T3 cells | Sarcoma | Exons | Genes | Medical genetics | Sequencing | Oncogenes | Tumors | Cancer | Translocation | Uterine neoplasm | Cytogenetic aberration | NUT | Leiomyosarcoma | CELLS | ACTIVATION | translocation | cytogenetic aberration | uterine neoplasm | MULTIDISCIPLINARY SCIENCES | SUBCELLULAR-LOCALIZATION | TUMORS | 14-3-3-PROTEINS | leiomyosarcoma | BREAST-CANCER | GROWTH | GENES | PROTEINS | CARCINOMA | Translocation, Genetic | Oncogene Proteins, Fusion - metabolism | Humans | Gene Expression Regulation, Neoplastic | Transcriptome | Molecular Sequence Data | Gene Expression Profiling | Neoplasm Proteins - metabolism | Chromosomes, Human, Pair 17 - genetics | Sarcoma, Endometrial Stromal - pathology | Cell Nucleus - metabolism | Neoplasm Grading | Cell Transformation, Neoplastic - genetics | Female | Cytogenetic Analysis | 14-3-3 Proteins - genetics | Sarcoma, Endometrial Stromal - metabolism | Sequence Analysis, DNA | Disease Progression | Genome, Human - genetics | Protein Transport | 14-3-3 Proteins - metabolism | Protein Binding | Sarcoma, Endometrial Stromal - genetics | Chromosomes, Human, Pair 10 - genetics | Gene Rearrangement - genetics | Cell Transformation, Neoplastic - pathology | Genetic aspects | Research | Uterine tumors | Gene expression | Genomics | Binding sites | Index Medicus | Biological Sciences
Journal Article
by Sieh, Weiva, PhD and Köbel, Martin, Dr and Longacre, Teri A, Prof and Bowtell, David D, Prof and deFazio, Anna, PhD and Goodman, Marc T, PhD and Høgdall, Estrid, PhD and Deen, Suha, Prof and Wentzensen, Nicolas, MD and Moysich, Kirsten B, Prof and Brenton, James D, MD and Clarke, Blaise A, MD and Menon, Usha, Prof and Gilks, C Blake, Prof and Kim, Andre, MPH and Madore, Jason, MS and Fereday, Sian, BSc and George, Joshy, MEng and Galletta, Laura, BSc and Lurie, Galina, MD and Wilkens, Lynne R, DrPH and Carney, Michael E, MD and Thompson, Pamela J, MPH and Matsuno, Rayna K, PhD and Kjær, Susanne Krüger, Prof and Jensen, Allan, PhD and Høgdall, Claus, Prof and Kalli, Kimberly R, PhD and Fridley, Brooke L, PhD and Keeney, Gary L, MD and Vierkant, Robert A, MS and Cunningham, Julie M, PhD and Brinton, Louise A, PhD and Yang, Hannah P, PhD and Sherman, Mark E, MD and García-Closas, Montserrat, Prof and Lissowska, Jolanta, PhD and Odunsi, Kunle, Prof and Morrison, Carl, MD and Lele, Shashikant, Prof and Bshara, Wiam, MD and Sucheston, Lara, PhD and Jimenez-Linan, Mercedes, MD and Driver, Kristy, BSc and Alsop, Jennifer, BA and Mack, Marie and McGuire, Valerie, PhD and Rothstein, Joseph H, MS and Rosen, Barry P, Prof and Bernardini, Marcus Q, MD and Mackay, Helen, MD and Oza, Amit, Prof and Wozniak, Eva L, BSc and Benjamin, Elizabeth, MD and Gentry-Maharaj, Aleksandra, PhD and Gayther, Simon A, Prof and Tinker, Anna V, MD and Prentice, Leah M, PhD and Chow, Christine, BMLSc and Anglesio, Michael S, PhD and Johnatty, Sharon E, PhD and Chenevix-Trench, Georgia, Prof and Whittemore, Alice S, Prof and Pharoah, Paul DP, Prof and Goode, Ellen L, PhD and Huntsman, David G, Prof and Ramus, Susan J, PhD
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 853 - 862
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2016, Volume 115, Issue 8, pp. 993 - 999
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 03/2017, Volume 123, Issue 5, pp. 802 - 813
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2009, Volume 9, Issue 1, pp. 433 - 433
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4086 - 4094
Journal Article
PLoS Medicine, ISSN 1549-1277, 12/2008, Volume 5, Issue 12, pp. 1749 - 1760
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 19, pp. 1835 - 1848
Journal Article